Business Description
Cerenome Inc. is a Houston-based pharmaceutical company focused on developing and bringing to market new treatments for cancer patients. Its most advanced therapy, rhenium obisbemeda, is a patented radiotherapy designed for brain cancers such as glioblastoma, leptomeningeal metastases, and pediatric brain tumors, while a separate treatment targets primary and secondary liver cancers through direct arterial delivery. The company also offers a diagnostic test to detect cancer cells that have spread to the central nervous system and is building an AI-powered platform to help guide treatment decisions in precision oncology.
